Perturbation of endoplasmic reticulum (ER) functions can have critical consequences for 27 cellular homeostasis. An elaborate surveillance system known as ER quality control (ERQC) 28 ensures that only correctly assembled proteins reach their destination. Persistence of 29 misfolded or improperly matured proteins upregulates the unfolded protein response (UPR) to 30 cope with stress, activates ER associated degradation (ERAD) for delivery to proteasomes for 31 degradation. We have identified a Brucella abortus type IV secretion system effector called 32
Introduction 43
The endoplasmic reticulum (ER) is the largest organelle in the cell and plays numerous 44 functions vital for maintaining cellular homeostasis. It is the major site for protein synthesis 45 of both secreted and integral membrane proteins as well as exporting of newly synthesised 46 proteins to other cellular organelles. Disturbance or saturation of the folding-capacity of the 47 ER leads to a complex stress response that has evolved to help cells recover homeostasis or, if 48 necessary, commit them to death. The ER relies on a complex surveillance system known as 49 ER quality control (ERQC) that ensures handling of misfolded, misassembled or 50 metabolically regulated proteins (Braakman and Bulleid, 2011) . Once retained in the ER, 51 these proteins are retrotranslocated back into the cytosol to be ubiquitinated and degraded by 52 the proteasome, a process known as ER-associated degradation (ERAD) (Wu and Rapoport, 53 2018) . Alternatively, ERAD-resistant proteins can be degraded via ERQC-autophagy (Houck 54 et al., 2014) . 55 56 In response to ER perturbations, particularly following the accumulation of toxic amounts of 57 misfolded proteins, ER stress ensues and cells activate a set of inter-connected pathways that 58 are collectively referred to as the unfolded protein response (UPR) that have a critical role in 59 restoring homeostasis (Walter and Ron, 2011) . The UPR is regulated by three ER membrane 60 sensors, the inositol-requiring enzyme I (IRE1), double-stranded RNA-activated protein 61 kinase-like ER kinase (PERK) and activating transcription factor 6 (ATF6). In non-stress 62 conditions these are kept inactive thanks to their association with the ER chaperone BiP. 63
Upon stress, BiP is dislodged from the luminal domains of the three sensors which leads to 64 their activation and induction of specialized transcriptional programs. The IRE1 and ATF6 65 pathways are involved in induction of the transcription of genes encoding for protein-folding 66 chaperones and ERAD-associated proteins (Hetz and Papa, 2018) . Whereas PERK sensing is 67 of IRE1 is also important for Brucella trafficking and subsequent Brucella multiplication (Qin 93 et al., 2008; Smith et al., 2013) . After cellular uptake, Brucella is found in a membrane bound 94 compartment designated endosomal Brucella-containing vacuole (eBCV) which transiently 95 interacts with early and late endosomes, undergoing limited fusion with lysosomes (Starr et 96 al., 2008) . Bacterial are then able to sustain interactions with ER exit sites (ERES) a process 97 that requires the activity of the small GTPases Sar1 (Celli et al., 2005) and Rab2 (Fugier et 98 al., 2009 ) and results in the establishment of an ER-derived compartment suited for 99 multiplication (replicative or rBCV). UPR induction by Brucella is necessary for this 100 trafficking step, as the formation of rBVCs is dependent on IRE1 activation by the ERES-101 localized protein Yip1A, which mediates IRE1 phosphorylation and dimerization (Taguchi et 102 al., 2015) . Once rBCVs are established, Brucella is capable of extensive intracellular 103 replication, without induction of cell death. Instead, at late stages of the intracellular cycle, 104 rBCVs reorganize and fuse to form large autophagic vacuoles (aBCVs) that will mediate 105 bacterial exit from infected cells (Starr et al., 2011) . The bacterial factors behind the switch 106 between rBCVs and aBCVs remain uncharacterized. 107 108 Brucella relies on a type 4 secretion system (T4SS), encoded by the virB operon and induced 109 during eBCV trafficking to translocate bacterial effectors into host cells and directly modulate 110 cellular functions. However, only a few effectors have been characterized and for which we 111 have a full grasp of how they contribute towards pathogenesis. This system has been 112 implicated in the induction of UPR during infection and a subset of these effectors has been 113 shown to modulate ER-associated functions. VceC interacts with the ER chaperone BiP to BspF have all been implicated in blocking of ER secretion (Myeni et al., 2013) . In particular, 117 BspB was shown to interact with the conserved oligomeric Golgi (COG) complex to redirect 118 vesicular trafficking towards the rBCVs (Miller et al., 2017) . Several other effectors that 119 localize in the ER when ectopically expressed have been shown to induce UPR or control ER 120 secretion, but the mechanisms involved remain uncharacterized. 121
122
In this study, we identify a new T4SS effector of Brucella abortus, that we designate as 123
Brucella-secreted protein L (BspL) that targets a component of the ERAD machinery, Herp. 124
BspL enhances ERAD and delays the formation of aBCVs, preventing early bacterial release 125 from infected cells which helps maintain cell to cell spread efficiency. Bacterial effectors are often similar to eukaryotic proteins or contain domains and motifs that 132 are characteristic of eukaryotic proteins. Multiple bacterial effectors benefit from the host 133 lipidation machinery for targeting eukaryotic membranes. Some of these contain a carboxyl-134 terminal CAAX tetrapeptide motif (C corresponds to cysteine, A to aliphatic amino acids and 135 X to any amino acid) that serves as a site for multiple post-translation modifications and 136 addition of a lipid group which facilitates membrane attachment, such as SifA from 137 Salmonella enterica (Boucrot et al., 2003; Reinicke, 2005) which showed the highest level of secretion at 24h post-infection in our experimental 151 conditions ( Figure 1A ). We found that TEM1-BspL was secreted into host cells as early as 4h 152 post-infection, with a slight peak at 12h post-infection, CCF2 cleavage was still detected at 153 24h post-infection ( Figure 1A ). This phenotype was fully dependent on the T4SS as a ∆ virB9 154 mutant strain did not show any coumarin fluorescence ( Figure 1A and B ). This was not due to 155 lack of expression of TEM1-BspL as both the wild-type and the ∆ virB9 strains carrying the 156 bla::bspL plasmid showed equivalent levels of TEM1-BspL expression ( Figure 1C ). 157
Together, these results show BspL is a T4SS effector. 158 159 Ectopically expressed BspL accumulates in the ER, does not interfere with host protein 160
secretion but induces the UPR 161
BspL is very well conserved in the Brucella genus, it is 170 amino acids long ( Figure S1A ) 162 and is approximately 19 kDa. BspL does not share any homology to eukaryotic proteins nor 163 to other bacterial effectors. Its nucleotide sequence encodes for a sec secretion signal, a 164 feature commonly found in other Brucella effectors (Marchesini et al., 2011) . In addition, it 165 contains a hydrophobic region that may constitute a transmembrane domain as well as a 166 proline rich region, with seven consecutive prolines that may be relevant in interactions with 167 eukaryotic proteins. To gain insight into the function of BspL we ectopically expressed HA, 168 myc or GFP-tagged BspL in HeLa cells. We found BspL accumulated in the ER, as can be 169 seen by the co-localization with calnexin ( Figure 2A and S1B, S1C), an ER membrane 170 protein and chaperone. Unlike what has been reported for VceC (de Jong et To determine the impact of BspL on host protein secretion we used the secreted embryonic 184 alkaline phosphatase (SEAP) as a reporter system. HEK cells were co-transfected with the 185 vector encoding SEAP and vectors encoding different Brucella effectors. We chose to work 186 with HA-BspL, to allow direct comparison with previously published HA-BspB that blocks 187 ER secretion and HA-BspD as a negative control (Myeni et al., 2013) . Expression of the 188 GDP-locked allele of the small GTPase Arf1[T31N], known to block the early secretory 189 pathway, was used as a control for efficient inhibition of secretion ( Figure S1D ). As 190 previously reported, we found that expression of HA-BspB drastically reduced SEAP 191 secretion ( Figure S1D ). In contrast, HA-BspL did not impact SEAP secretion to the same 192 extent as BspB, having an effect equivalent to HA-BspD previously reported not to affect host 193 protein secretion (Myeni et al., 2013) . involved apoptosis. We therefore monitored XBP1s and CHOP transcript levels following 204 ectopic expression of HA-BspL, in comparison to HA-VceC, established as an ER stress 205 inducer and HA-BspB, known not to induce ER stress. Treatment with tunicamycin, a 206 chemical ER stress inducer was also included. We found that over-expression of HA-BspL 207 induced an increase of both XBP1s and CHOP transcription, to levels even higher than HA-208 VceC ( Figure 2B comparison with the wild-type. Two cellular models were used, HeLa cells and an 216 immortalized cell line of bone marrow-derived macrophages (iBMDM). We found that the 217 ∆ bspL strain replicated as efficiently as the wild-type in both iBMDM ( Figure S2A ) and 218 HeLa cells ( Figure S2B ). In terms of intracellular trafficking no obvious differences were 219 observed in the establishment of rBCVs at 24 and 48h post-infection, as ∆ bspL BCVs were 220 nicely decorated with the ER marker calnexin in both cell types ( Figure 2D and E) as 221 observed for the wild-type strain ( Figure S2C and D). As this is the first report to our 222 knowledge to use iBMDM in Brucella infections, we confirmed this observation by 223 quantifying the percentage of BCVs positive for calnexin and the lysosomal associated 224 membrane protein 1 (LAMP1) in comparison with the wild-type at 24 and 48 post-infection 225 ( Figure S2E and F, respectively). The wild-type strain in this cellular model behaved as 226 expected forming the typical rBCVs. 227
228
As in transfected cells we found that BspL induced UPR, we next monitored the levels of 229
XBP1s and CHOP transcripts during infection. Since the rate of infected cells is too low to 230 detect ER stress in HeLa cells, these experiments were only performed in iBMDMs. As 231 expected, the wild-type B. abortus strain induced an increase in the levels of transcription of 232
XBP1s in relation to the mock-infected control iBMDM at 48h post-infection ( Figure 2F ). In 233 contrast, ∆ bspL infected macrophages showed decreased XBP1s transcript levels compared to 234 the wild-type ( Figure 2G ). Furthermore, the wild-type phenotype could be fully restored by 235 expressing a chromosomal copy of bspL in the ∆ bspL strain, confirming that BspL 236 specifically contributes towards induction of the IRE1 branch of the UPR during infection 237 ( Figure 2F ). We did not observe an increase in CHOP transcript levels in iBMDM infected 238 with the wild-type nor ∆ bspL strains in comparison to the mock-infected cells ( Figure 2G constitute an interesting target. Herp is an ER membrane protein playing a role in both the 256 UPR and the ERAD system whereas Ubiquilin2 is implicated in both the proteasome and 257 ERAD and, interestingly, shown to interact with Herp (Kim et al., 2008) . In view of these 258 different targets we decided to carry out an endogenous co-immunoprecipitation in cells 259 expressing HA-BspL. As controls for detecting non-specific binding, we also performed co-260 immunoprecipitations from cells expressing two other ER-targeting effectors, HA-BspB and 261 HA-VceC. We then probed the eluted samples with antibodies against Alex3, Ubiquilin2 or 262
Herp to detect if any interactions could be observed. We found that Alex3 was co-263 immunoprecipitated with all 3 effectors suggesting a potentially non-specific interaction with 264 the effectors or the resin itself ( Figure 3A) . In contrast, no interactions were observed with 265
Ubiquilin2, which was detected only in the flow through fractions. However, we found that 266 endogenous Herp specifically co-immunoprecipated with HA-BspL and not the other 267 effectors ( Figure 3A ), suggesting Herp and BspL form a complex within host cells. Taken 268 together with the yeast two-hybrid data, we can conclude that BspL directly interacts with 269 Herp. Consistently, over-expressed BspL co-localized with Herp by microscopy ( Figure 3B is becomes glycosylated and fails to assemble. This in turn induces its retrotranslocation back 285 to the cytosol to be degraded by the proteasome. Cycloheximide treatment for 4 h was used to 286 block protein synthesis, preventing replenishment of TCR pools and allowing for 287 visualization of ERAD-mediated degradation of TCRα. When HEK-293T cells, which do not 288 naturally express TCR were transfected with HA-TCRα and treated with cycloheximide, a 289 decrease in HA-TCRα was observed, indicative of degradation ( Figure 4A , red arrow). 290
Strikingly, expression of BspL induced very strong degradation of TCRα ( Figure 4A ). This is 291 accompanied by the appearance of a faster migrating band at around 25 KDa (blue arrow), 292 that nearly disappears upon cycloheximide treatment suggesting this TCRα peptide is 293 efficiently degraded by the proteasome. It is important to note that the 25 KDa band is also 294 present when HA-TCRα is expressed alone (lane 2 of Figure We therefore treated samples with EndoH, which deglycosylates peptides. Upon EndoH 306 treatment we observed deglycosylated HA-TCRα (second lane, Figure 4B , black arrow), 307 confirming the reporter system is being processed normally. In the BspL expressing samples 308 (lanes 3 and 4, Figure 4B ), a slight band corresponding to the non-glycosylated TCRα could 309 also be detected particularly after EndoH treatment, confirming that BspL does not prevent 310
TCRα from entering the ER and being glycosylated. The dominant TCRα band induced upon 311
BspL expression (around 25 KDa, blue arrow) migrates faster than the non-glycosylated form 312 resulting from EndoH treatment (black arrow) and does not appear to be sensitive to EndoH. 313 This may therefore correspond to a natural truncated non-glycosylated form of HA-TCRα. 314
Consistently, this band is also present in the absence of BspL (lane 1, Figure 4B , blue arrow). 315
Together these data indicate that BspL is a strong inducer of ERAD. 316
317

ERAD is required for different stages of intracellular lifecycle of Brucella 318
The role of ERAD in the Brucella intracellular life cycle has not yet been investigated to our 319 knowledge. We therefore decided to block ERAD using eeyarestatin, an established inhibitor 320 of this system. Unfortunately, prolonged treatment at the concentration necessary for full 321 inhibition of ERAD induced detachment of infected iBMDM. Nonetheless, we were able to 322 carry out this experiment in HeLa cells, which showed significant resistance to the 323 eeyarestatin treatment. Total CFU counts after addition of eeyarestatin at 2h post-infection 324 showed a significant decrease in bacterial counts at 48h, suggesting a potential inhibition of 325 replication ( Figure 5A ). However, microscopy observation of infected cells at this time-point 326 clearly showed extensive replication of bacteria even in the presence of eeyarestatin (Figure 327 5B), suggesting that the drop of CFU observed was a result of exit of bacteria from infected 328 cells rather than inhibition of intracellular replication. Consistently, we observed significant 329 numbers of extracellular bacteria as well as many cells infected with only a few bacteria 330 potentially resulting from re-infection. These results suggest that blocking of ERAD during 331 early stages of infection would favour intracellular replication. To confirm this possibility, we 332 counted by microscopy the number of bacteria per cell at 24h post-infection and indeed found 333 a higher replication rate upon eeyarestatin treatment ( Figure 5C ). We therefore hypothesized 334 that Brucella might block ERAD during early stages of the infection to favour establishment 335 of an early replication niche, a phenotype clearly not dependent on BspL, as we have shown it 336 is not implicated in the establishment of rBCVs and when ectopically expressed it induces 337 ERAD. We therefore, wondered if BspL could intervene at a later stage of the infection to 338 induce ERAD via its interaction with Herp. 339 340
BspL delays premature bacterial egress from infected cells 341
The late stage of the intracellular cycle of Brucella relies on induction of specific autophagy 342 proteins to enable the formation of aBCVs characterized as large vacuoles with multiple 343 bacteria decorated with LAMP1 (Starr et al., 2011) . In our experimental conditions aBCVs 344 could be clearly observed in iBMDM infected for 65h with wild-type B. abortus ( Figure 6A ). 345
We therefore investigated if BspL was involved in formation of aBCVs. Strikingly, ∆ bspL 346 aBCVs could be detected as early as 24h, with nearly 30% of infected cells showing aBCVs 347 at 48h post-infection compared to less than 10% for wild-type infected cells ( Figure 6B In this study, we characterize a previously unknown T4SS effector of B. abortus and its role 363 in virulence. We found this effector hijacks the ERAD machinery to regulate the late stages of 364 the Brucella intracellular cycle. Although many bacterial pathogens have been shown to 365 control UPR, very little is known about the impact of ERAD, a downstream process following 366 UPR, in the context of intracellular bacterial infections. To our knowledge there are only two 367 examples. The obligatory intracellular pathogen Orientia tsutsugamushi, the cause of scrub 368 thypus, is an auxotroph for histidine and aromatic amino acids and was shown to transiently 369 induce UPR and block ERAD during the first 48h of infection (Rodino et al., 2017) . This in 370 turn enables release of amino acids in the cytosol, necessary for its growth (Rodino et al., 371 2017) . The second example is Legionella pneumophila, that recruits the AAA ATPase 372
Cdc48/p97 to its vacuole, that normally recognizes ubiquitinated substrates and can act as a 373 chaperone in the context of ERAD to deliver misfolded proteins to the proteasome. 374
Recruitment of Cdc48/p97 to the Legionella vacuole is necessary for intracellular replication 375 and helps dislocate ubiquitinated proteins from the vacuolar membrane, including bacterial 376 effectors (Dorer et al., 2006) . 377
378
In the case of BspL we found it directly interacts with Herp, a component of ERAD which is 379 induced upon UPR. Our data suggest that BspL enhances ERAD and this prompted us to 380 further investigate the role of ERAD during Brucella infection. Interestingly, we found that 381 inhibition of ERAD is beneficial during early stages of intracellular trafficking and enhances 382 bacterial multiplication. It is possible that Brucella is transiently blocking ERAD during 383 rBCV formation and initial replication, potentially via a specific set of effectors or a particular 384
cellular signal yet to be identified. This could, as demonstrated for Orientia, release amino 385 acids into the cytosol that would be critical for bacterial growth. Alternatively, or in parallel, a 386 block of ERAD could potentially enhance autophagy to deal with the ER stress that would in 387 turn favour rBCV formation. binding but perhaps a weak or transient interaction is taking place not detectable with our 417 current in vitro conditions. Another interesting target is Bag6, (also known as Bat3) a 418 chaperone of the Hsp70 family that is also involved in delivery of proteins to the ER or when 419 they are not properly folded to the proteasome. Bag6 was shown to be the target of the 420
Orientia Ank4 effector that blocks ERAD (Rodino et al., 2017) and to be targeted by multiple 421
Legionella effectors to control host cell ubiquitination processes (Ensminger and Isberg, 422 2010 ). Therefore, it is possible that Bag6 may contribute towards BspL control of ERAD 423 functions during Brucella infection. 424
425
In addition to ERAD, we found that BspL itself was implicated in induction of UPR. 426
However, this phenotype was independent of Herp and may be an indirect effect due to its ER 427 accumulation or via another cellular target yet to be characterized. Furthermore, the increased 428 ERAD activity upon BspL expression was not a result of increased ER stress; suggesting that 429 BspL is independently controlling these two pathways. There is growing evidence that the comparisons test was used and yielded non-significant differences. 614 HEK 293T cells were transfected with HA-TCRα in the absence or presence of myc-BspL 640 for 24h. Where indicated, cells were treated with 50 µg/ml cycloheximide for the last 6h or 641 0.5 nM of TUDCA for 22h. The blot was probed first with an anti-TCR antibody followed by 642 anti-actin. The same samples were loaded onto a separate (separated by dashed line) for 643 probing with an anti-myc and anti-actin to confirm the expression of myc-BspL. Molecular 644 weights are indicated (KDa) and relevant bands described in the text highlighted with 645 different coloured arrows. transferred onto PVDF membrane Immobilon-P (Millipore) using a standard liquid transfer 763 protocol. Membranes were blocked using PBS with 0.1% Tween 20 and 5% skim milk for 30 764 min and the probed using relevant primary antibodies overnight at 4 °C, washed 3 times with 765 PBS with 0.1% Tween 20 and then incubated with HRP-conjugated secondary anti-goat, 766 mouse or rabbit antibodies, diluted in PBS with Tween 20 0.1% and 5% skim milk for 1 h. 767
Western blots were revealed using ECL Clarity reagent (BioRad). Signals were acquired 768 using a Fusion Camera and assembled for presentation using Image J. 769 770 TEM1 translocation assay 771 RAW cells were seeded in a 96 well plates at 1x10 4 cells/well overnight. Cells were then 772 infected with an MOI of 300 by centrifugation at 4 °C, 400 g for 5 min and 1 at 37 °C 5% 773 CO 2 . Cells were washed with HBSS containing 2.5 mM probenicid. Then 6 µl of CCF2 mix 774 (as described in the Life Technologies protocol) and 2.5 mM probenicid were added to each 775 well, and incubated for 1.5 h at room temperature in the dark. Cells were finally washed with 776 PBS, fixed using Antigenfix and analysed immediately by confocal microscopy (Zeiss 777 LSM800). 778
779
RNA isolation and real-time quantitative polymerase chain reaction (qRT-PCR) 780
HeLa cells were seeded in 100x100 culture dishes at 1x10 6 cells/plate for each condition and 781 were either transfected with HA-tagged BspL, VceC or BspB for 24h or infected with wild-782 type, mutant or complemented strains for 48h. Cells were then washed 1x in PBS, scrapped in 783 buffer RLT (Qiagen) supplemented with ß-mercaptoethanol and transfered on a Qiashredder 784 column (Qiagen). Then several wash steps were performed and total RNAs were extracted 785 HEK293T cells seeded in 100 mm culture plates at 8x10 5 cells/plate overnight and then co-807 transfected for 24h with Torpedo (Ibidi) with vectors encoding HA-TCR (5 µg) and myc-808 BspL (5 µg). Cycloheximide 50 µg/ml was added 6h before lysis. Where indicated, TUDCA 809 was added 2h after transfection at 0.5 mM. Cells were harvested as described above (western 810 blotting) and lysed in 200 µl of lysis buffer (Chromotek). EndoH (New England Biolabs) 811 treatment was carried out following the manufacturers protocol for 1h at 37 °C. Sample buffer 812 was then added (30 mM Tris-HCl pH 6.8, 1% SDS, 5% glycerol, 0.025% bromophenol blue 813 and 1.25 ß-mercaptoethanol final concentration). Western blotting was done as described 814 above using anti-TCR antibody. Actin levels were also analyzed as a loading control. 815 816 Secretion assay 817 HEK293T cells were harvested and seeded in 6-well plates at 1x10 5 cells/well and co-818 transfected with plasmids encoding Brucella secreted proteins (300 ng DNA) and the secreted 819 embryonic alkaline phosphatase (SEAP) (300 ng DNA) provided by Jean Celli. Total amount 820 of transfected DNA was maintained constant using an empty vector pcDNA 3.1 for the 821 positive control. At 18 h post transfection, the transfection media was removed and then cells 822 were still incubated at 37°C 5% CO 2 . Fourty-eight hours later, media containing culture 823 supernatant (extracellular SEAP) was removed and collected. To obtain intracellular SEAP, 824 each well was washed with PBS and then incubated with a solution of PBS-Triton X-100 825 0.5% for 10 minutes. An incubation of each fraction was performed at 65 °C following a 826 centrifugation at maximum speed for 30 seconds. Then cells were incubated with a provided 827 substrate 3-(4-methoxyspiro [1,2-dioxetane-3,2'(5'-chloro)-tricyclo(3.3.1.13,7) decane]-4-828 yl)phenyl phosphate (CSPD) by SEAP reporter gene assay, chemiluminescent kit (Roche 829 Applied Science). Chemiluminescence values were obtained with the use of a TECAN at 492 830 nm. Data are presented as the SEAP secretion index, which is a ratio of extracellular SEAP 831 activity to intracellular SEAP activity. 832 833
Yeast two-hybrid 834
BspL was cloned into pDBa vector, using the Gateway technology, transformed into MaV203 835 and used as a bait to screen a human embryonic brain cDNA library (Invitrogen). Media, 836 transactivation test, screening assay and gap repair test were performed as described Weaver and Szostak, 1983; Thalappilly et al., 2008; Walhout and Vidal, 2001) . 838
All drug treatments are indicated in the specific protocols. To summarize the concentrations 863 used were: TUDCA (Focus Biomolecules) at 0.5 nM; Cycloheximide (Sigma) at 50 µg/ml; 864 Eeyarstatin (Sigma) at 8 µM; Tunicamycin (Sigma) at 1 µg/µl; Probenicid (Sigma) at 2.5 865 mM. 866 867
Co-immunoprecipitation 868
HeLa cells were cultured in 100 mm x 20 mm cell culture dishes at 1x10 6 cells/dish 869 overnight. Cells were transiently transfected with 30 uL of Torpedo DNA (Ibidi) for 24h for a 870 total of 10 µg of DNA/plate. On ice, after 2 washes with cold PBS cells were collected with a 871 cell scraper and centrifuged at 80g at 4 °C during 10 min. Cell lysis and processing for co-872 immunoprecipitation were done as described with the PierceTM HA Epitope Antibody 873
Agarose conjugate (Thermo scientific). 874 875
Statistical analysis 876
All data sets were tested for normality using Shapiro-Wilkinson test. When a normal 877 distribution was confirmed a One-Way ANOVA test with a Tukey correction was used for 878 statistical comparison of multiple data sets with one independent variable and a Two-Way 879 ANOVA test for two independent variables. For data sets that did not show normality, a 880 Kruskall-Wallis test was applied, with Dunn's correction, or Mann-Whitney U-test for two 881 sample comparison. All analyses were done using Prism Graph Pad 6. 882 883
